TEST

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
Covid2
Loc RT-PCT Lab @ Purasawalkam
Loc No.935, P.H.Road, Purasawalkam,
 Chennai - 600084.
Loc (Next to Blue Diamond Hotel)
Loc 9345612448, 9345650993
Loc 9345662303, 9345709039
 Special On-Site services available for
 factories and Companies. Contact :
LocSenthil : 8825611543
LocYamini : 7397332352
LocGanesan : 9840950389

Test


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others

Note: Test Details are subject to change without any prior notice. Please confirm with the respective branches for current Details.
 
  C Top

Sno. Test Name Amount  Min Qty Ref. Value
1     C - PEPTIDE ( PP) 750   1 ml Fasting Values : 1.1 - 4.4. ng/ml.
PP values are higher than the fasting levels and are dependent on the nature of Diet.No separate PP reference values are available.

C-Peptide values are decreased in Type 1 Diabetes Mellitus.

Increased in Hyperinsulinism,Obesity and Renal Insufficiency.
2     C - PEPTIDE ( Random) 750   1 ml
3     C - PEPTIDE PROFILE 2800   1 ml
4     C - PEPTIDE ( FASTING) 750   1 ml 1.1-4.4 ng/ml

C-Peptide values are decreased in Type 1 Diabetes Mellitus.

Increased in Hyperinsulinism,Obesity and Renal Insufficiency.
5     c KIT MUTATION SCREENING - AML 9000  
6     C- ANCA 1000   500ul
7     C.M.V Avidity 1000   Low Avidity : Below 30 %
Borderline IgG Avidity : 30 - 40 %
High Avidity : Above 40 %

Detection of a low IgG avidity along with positive IgM & IgG levels is a reliable indicator for Primary (recent) Cytomegalovirus infection. Detection of high IgG avidity along with positive IgG levels shows that the infection has occurred in the past (> 2-4 months).
In some cases, positive Cytomegalovirus IgM antibodies can persist for several months or years after primary infection in an individual. Persistence of low avidity following infection is not uncommon.
Cytomegalovirus Avidity IgG testing results should be interpreted in conjunction with results of Cytomegalovirus IgG and Cytomegalovirus IgM.
In absence of Cytomegalovirus IgG result, avidity testing is inconclusive
8     C.M.V IGG AB (CYTOMEGALO VIRUS) 350   1 ml Less than 0.5 U/ml : Negative
0.5 - 1.0 U/ml : Equivocal
More than or Equal to 1.0 U/ml : Positive

CMV usually causes mild and asymptomatic infections, but may pose a significant medical risk in pregnant women, new born and immunocompromised individuals.

CMV IgG Positive test indicates past or acute infection. BY the age of 25 years most of the population will be positive for CMV IgG.

All results should be interpreted by treating physician with additional relevant diagnostic information and clinical findings.

Precaution: In immunocompromised patients, CMV serology (IgG or IgM antibody titres) may not be reliable and may be misleading in the diagnosis of acute or reactivation of CMV disease. The preferred method for diagnosis is CMV Viral Load Testing.

9     C.M.V IGM AB (CYTOMEGALO VIRUS) 350   1 ML Less than 0.70 COI : Negative
0.70 - 1.00 COI : Equivocal
More than 1.00 COI : Positive

CMV usually causes mild and asymptomatic infections, but may pose a significant medical risk in pregnant women, new born and immunocompromised individuals.

In utero infection can lead to varying degrees of mental retardation, chorioretinitis, hearing loss and neurologic problems.

Equivocal results should be retested after 2 weeks.

Positive test results indicate primary infection, reinfection or reactivation of latent virus. It is recommended to confirm the clinical relevance of reactive results by CMV Viral Load Testing .

All results should be interpreted by treating physician with additional relevant diagnostic information and clinical findings.
10     C.M.V. IGG AB(CSF) 250  
11     C.M.V. IGM AB (CSF) 250  
12     C.R.P. 300   0.5 ml
Neonates Less than 3 weeks :< 4.1 mg/l
Children 2 months to 15 yrs:< 2.8 mg/l


Adults :Less than 5.0 mg/l
13     C.S.F. CULTURE & SENSITIVITY 750  
14     C.S.SPINT OPEN MOUTH 300  
15     C.SPINE EXTENSION 300  
16     C.SPINE FLEXION 300  
17     C.SPINE OBLIQUE LEFT 300  
18     C.SPINE OBLIQUE RIGHT 300  
19     C1 Esterase Inhibitor 3000   195 - 345 mg/L

C1 inactivator deficiency is one of the commonest inherited complement deficiencies leading to Hereditary Angioedema. This deficiency is of two types :

1.Type I ( reduced serum levels of functionally active C1 inactivator)

2.Type II (normal or elevated levels of functionally inactive C1 inactivator)

Acquired C1 esterase inhibitor deficiency is rare and all reported cases have been secondary to Lymphomas or Myelomas.

Please Correlate Clinically.
20     C3 (COMPLEMENT C3) 500   1 ml 90 - 180 mg/dl
21     C4 ( COMPLEMENT C4) 500   0.5 ml 10 - 40 mg/dl.
22     CA 125 700   1 ml Less than 35.0 U/ml

CA 125 levels are increased in Ovarian Tumours of Epithelail origin. Minor elevations are also seen in Benign Ovarian Cysts, Endometriosis , TB of Abdomen and Pelvic Inflammatory Disease. Please correlate with Clinical and Imaging Data.
23     CA 19 - 9 800   1 ml 0 - 39.0 U/ml

CA 19-9 Levels are increased in Obstructive Jaundice, pancreatitis, Cirrhosis of Liver and very high levels in Carcinoma of Pancrease.
HIgher levels of CA 19 -9 alone cannot be used for Diagnosis of CA.Pancreas and must be correlated with other clinical and imaging data.
Can be used for follow up of Patients after surgery for Pancreatic Carcinoma.

24     CA - 125 ( ASCITIC FLUID) 500   No reference value available.
Reference value for Blood : Less than 35.0 U/ml.
25     CA - 15 - 3 800   1 ml Less than 34.5 U/ml

CA 15-3 Levels should be used only for detection of recurrence in previously treated patients and monitoring response to therapy. Should not be used for Diagnosis or Screening for Breast Cancer. For Diagnosis and screening Clinical Breast examination and mammogram should be used.

Note : Kindly note the changes in reference interval.
26     CA 19 - 9 (PANCREATIC FLUID) 600  
27     CA 27.29 12500   Less than 38 U/mL
28     CA 72 - 4 1700   5.6-8.2 U/ml


Elevated CA-72-4 levels are primarily used in monitoring treatment and disease course in patients with gastric cancer. In 70% of relapse cases, CA-72-4 increases prior or concurrently with clinical diagnosis of the relapse. Diagnostic sensitivity of CA-72-4 for gastric cancer increases to 66% when combination of CA-72-4,CEA,CA-125 and CA 19-9 are used. Can be elevated in ovarian and colorectal cancer.
Can also be found in certain non-malignant diseases like pneumonia, pancreatitis, liver cirrhosis and ovarian cysts.
29     Cabbage(f216) - SPECIFIC IgE 600   Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
30     CALCITONIN 4000   1 ML Female : 5.17 - 9.82 pg/ml
Male : 8.31 - 14.3 pg/ml
31     CALCIUM - DIALYSIS FLUID 150  
32     CALCIUM -SERUM 150   0.5 ML Children
0 - 10 Days : 7.6 - 10.4 mg/dl
10 days - 2 yrs : 9.0 - 11.0 mg/dl
2 - 12 yrs : 8.8 - 10.8 mg/dl
12 - 18 yrs : 8.4 - 10.2 mg/dl

Adults
18 - 60 yrs : 8.6 - 10.0 mg/dl
60 - 90 yrs : 8.8 - 10.2 mg/dl
More than 90 yrs: 8.2 - 9.6 mg/dl

33     Calprotectin- Fecal 3000   Less than 80.0 ug/g: Normal

80 - 160 ug/g: Gray Zone - repeat test after four weeks.

More than 160 ug/g: Positive

Calprotectin increased in Inflammatory Bowel Disease (IBD), Coeliac disease, infectious Colitis, necrotizing enterocilitis and colorectal cancer. The main IBD's are Ulcerative Colitis and Crohn's disease. Calprotectin usually normal in Irritable Bowel Syndrome (IBS).
False elevation of Calprotectin can be observed in patients taking non-steriodal anti-inflammatory drug (NSAID) and infective gastro enteritis.




34     CALR Mutation Analysis 6000  
35     Cancer Syndrome Gene Panel 25000  
36     Candida albicans( m5)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
37     CANNABINOIDS(URINE) 200  
38     CARBAMAZEPINE 750   0.5 ml Therapeutic Level : 4 - 12 Microgm/ml
39     CARDIOLIPIN AB IGA 600   1 ML Less than 12 APL/ml:Negative

12 to 18 APL/ml :Equivocal

More than 18 APL/ml:Positive
40     CARDIOLIPIN AB IGG 600   1 ml Less than 12 GPL/ml:Negative
12 - 18 GPL/ml :Equivocal
More than 18 GPL/ml:Positive
41     CARDIOLIPIN AB IGM 600   1 ML Less than 12 MPL/ml:Negative
12 - 18 MPL/ml :Equivocal
More than 18 MPL/ml:Positive


42     CARNITINE -SERUM 4500  
43     Carrot (f31) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
44     Casein ( f 78)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
45     Cat dander ( e100)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
46     Cat epithelium( e1)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
47     CATECHOLAMINES ( 24 HOURS URINE) 5500   10 ML 14 - 110 ug/24hrs

Catecholamines, including dopamine and norepinephrine, are the principal neurotransmitters that mediate a variety of the central nervous system functions, such as motor control, cognition, emotion, memory processing, and endocrine modulation.

Included among catecholamines are epinephrine (adrenaline), norepinephrine (noradrenaline), and dopamine, all of which are produced from phenylalanine and tyrosine.

Release of the hormones epinephrine and norepinephrine from the adrenal medulla of the adrenal glands is part of the fight-or-flight response.

Catecholamines cause general physiological changes that prepare the body for physical activity (fight-or-flight response). Some typical effects are increases in heart rate, blood pressure, blood glucose levels, and a general reaction of the sympathetic nervous system. Some drugs, like tolcapone (a central COMT-inhibitor), raise the levels of all the catecholamines.
48     CATECHOLAMINES ( PLASMA) 8000  
49     CATECHOLAMINES ( SPOT URINE) 5500  
50     CATHEPSIN - G 750   <1.0 Ratio: Negative
1.0 - 2.0 : Weak positive
2.0 - 5.0 : Positive
>5.0 : High Positive
51     Cauliflower(f291) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
52     CBC 300  
53     CD 38 1250  
54     CD 48 1250  
55     CD 10 1250  
56     CD 117 1250  
57     CD 11C 1250  
58     CD 13 1250   2 ml
59     CD 14 1250  
60     CD 15 1250  
61     CD 16 1250  
62     CD 19 1250   Normal : 8 % to 18 %

Ref : Int.Journal of Immunopathology & Pharmocology 2017 Jun30 (2) 194-200
63     CD 20 1250   Normal : 10 % to 20 %

Ref : Int.Journal of Immunopathology & Pharmocology 2017 Jun30 (2) 194-200
64     CD 200 1250   2 ml EDTA Blood or 2 ml Heparin Blood (Green Top)
65     CD 22 1250   2 ml EDTA Blood or 2 ml Heparin Blood (Green Top)
66     CD 23 1250  
67     CD 24 1250  
68     CD 25 1250  
69     CD 3 1250  
70     CD 33 1250  
71     CD 34 1250   2 ml
72     CD 41 1250  
73     CD 45 1250   2 ML
74     CD 5 1250  
75     CD 55 1250  
76     CD 56 1250  
77     CD 59 1250  
78     CD 64 1250  
79     CD 7 1250  
80     CD4 1250  
81     CD4/CD8 COUNT 1000   2 ML
82     CD8 1250  
83     CEA 750   1 ml Non.Smokers : Upto 5.0 ng/ml
Smokers : Upto 6.5 ng/ml

CEA levels are elevated in Carcinomas of Colon, Lung, Ovaries,Breast, Liver and Pancreas.

CEA levels can be used only for Monitoring and staging of the disease and not for Diagnosis.
84     CEA (ASCITIC FLUID) 500   No reference value available.
85     CEA (CYSTIC FLUID) 500  
86     CEA (PANCREATIC FLUID) 400  
87     CELL COUNT ( CYSTIC FLUID) 60  
88     CELL COUNT ( DIALYSIS FLUID) 60  
89     CELL COUNT ( PERITONEAL FLUID) 100  
90     CELL COUNT (ASCITIC FLUID) 100  
91     CELL COUNT (ASPIRATED FLUID) 60  
92     CELL COUNT(BRONCHIAL WASH) 60  
93     CELL COUNT(CSF) 100  
94     CELL COUNT(PERICARDIAL FLUID) 100  
95     CELL COUNT(PLEURAL FLUID) 100  
96     CELL BLOCK 800  
97     CELLCOUNT (SYNOVIAL FLUID) 100   Appearance : Colourless
WBC : 0 - 200/l
Neutrophils : Upto 20 %
Lymphocytes : Upto 15 %
Monocytes and Macrophages : Upto 65 %
98     Cephalosporin ( c7) - SPECIFIC IGE 600   1 ML Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
99     CERULOPLASMIN -SERUM 400   1 ml Male : 15 - 30 mg/dl
Female : 16 - 45 mg/dl
100     CERVICAL BIOPSY 500  
101     CERVICAL SPINE AP 300  
102     CERVICAL SPINE AP & LAT 500  
103     CERVICAL SPINE LAT 300  
104     CERVICAL SPINE OBLIQUE 300  
105     CFTR - 4 COMMON MUTATION 5000  
106     Cheese(cheddar type) ( f 81)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
107     CHEST AP VIEW 300  
108     CHEST For RIBS 300  
109     CHEST LATERAL VIEW (RIGHT) 300  
110     CHEST LATERAL VIEW (LEFT) 300  
111     CHEST MEASURMENT 10  
112     CHEST PA VIEW 300  
113     Chicken (f 83) - SPECIFIC IGE 600   1.0 ml Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
114     Chicken feathers (e 85) - SPECIFIC - IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
115     CHIKUNGUNYA IGM 600   1 Ml Chikungunya virus is transmitted by the bite of infected Aedes aegypti mosquito leading to Dengue like symptoms. Absence of IgM antibody does not exclude the possibility of Chikungunya infection. The test is a preliminary screening test and should not be interpreted in isolation, correlate clinically.
116     CHIKYNGUNYA BY RT PCR 2000  
117     CHLAMYDIA ANTIBODY IgM 600   1 ml Less than 0.90 A.I : Negative
0.90 - 1.10 A.I : Equivocal
More than 1.10 A.I : Positive
118     Chlamydia trachomatis IgA 600   1 ml Less than 0.80 Ratio: Negative
0.80 - 1.10 Ratio: Equivocal
More than 1.10 Ratio: Positive

Interpretation

Chlamydia trachomatis is the common cause of non-gonorrheal urethritis, lymphogranuloma venereum, trachoma and neonatal pneumonia . It also causes ophthalmologic infections. In males, epididymitis and Reiter syndrome occur. In Females, it causes pelvic inflamatory disease and endometritis.

Note: Serological results to chlamydia antibodies must be correlated with clinical history.
119     Chlamydia trachomatis IgG 600   1 ml Less than 0.80 Ratio : Negative
0.80 - 1.10 Ratio : Equivocal
More than 1.10 Ratio : Positive

Interpretation
Chlamydia trachomatis is the common cause of non-gonorrheal urethritis, lymphogranuloma venereum, trachoma and neonatal pneumonia . It also causes ophthalmologic infections. In males, epididymitis and Reiter syndrome occur. In Females, it causes pelvic inflamatory disease and endometritis.

Note: Serological results to chlamydia antibodies must be correlated with clinical history.

120     CHLAMYDIA DNA BY PCR 4000  
121     CHLORIDE ( ASCITIC FLUID) 200   0.5 ml
122     CHLORIDE ( CL - ) 200   Pre mature : 95 - 110 mmol/L
0 - 30 Days : 98 - 113 mmol/L

Adult : 98 - 107 mmol/L
123     CHLORIDE ( CL - )- DIALYSIS FLUID 200  
124     CHLORIDES (CSF) 200   118 - 132 mMol/L
125     CHOCOLATE (f 105) - SPECIFIC IGE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
126     CHOLESTEROL - SERUM 150   0.5 ml NCEP guidlines ATP III classification
(Coronary heart disease risk)

Child(upto19 yrs)
Less than 170 mg/dl : Desirable
170 - 199 mg/dl : Borderline High
>= 200 mg/dl : High

Adult(Above 19 yrs)
Less than 200 mg/dl : Desirable
200 - 239 mg/dl : Borderline High
>= 240 mg/dl : High
127     CHOLESTEROL(ASCITIC FLUID) 150  
128     CHOLINESTERASE 600   1.00 ML 3.93 - 10.80 kU/L

Cholinesterase is also called pseudocholinesterase. The main indicators for measuring pseudocholinesterase are:
1 . Monitoring exposure to cholinesterase inhibitors
2. As a liver function test
3. Diagnosis of genetic variants

Decreased levels

1. Organophosphate poisoning
2. Liver diseases like Acute hepatitis, Cirrhosis & Metastatic carcinoma to liver
3. Malnutrition



129     Chromogranin A 5000   Less than 100 ug/l

Chromagranin A is elevated in Chromagranin A secreting neuroendocrine tumours (NETs), such as Pheochromocytomas and carcinoids.
130     CHROMOSOME BREAKAGE SYNDROME 6000  
131     CHYLURIA 100   10 ml
132     CIBD PROFILE ( Chronic Inflammatory Bowel Disease) 5000  
133     CK ( CPK - TOTAL) -SERUM 300   0.5 ml Infants :-
1 Day : < 712 U/L
2 - 5 Days : < 652 U/L
6 Days - 6 Months : < 295 U/L
7 - 12 Months : < 203 U/L
Children
1 - 3 Yrs : < 228 U/L
4 - 6 Yrs : < 149 U/L
Male
7 - 12 Yrs : < 247 U/L
13 - 17 Yrs : < 270 U/L
Female
7 - 12 Yrs : < 154 U/L
13 - 17 Yrs : < 123 U/L

Adult Male : 20 - 200 U/L
Adult Female : 20 - 180 U/L

134     CK - MB - MASS - SERUM 500   1 ml Male :UPTO 6.22 ng/ml
Female :UPTO 4.88 ng/ml
135     Cladosporium herbarum(m2)- SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
136     CLAVICLE (LEFT) 300  
137     CLAVICLE (RIGHT) 300  
138     Clinical Exome Sequencing 25000  
139     CLL - TRISOMY 12 BY FISH 3500  
140     CLONIDINE STIMULATION TEST 1000  
141     Clopidogerel(Clopiret) Resistance Test 1000   Less than 5 Ohm ; Shows Antiplatelet effect
More tah 5.1 Ohms : Shows resistance
142     CLOPIDOGREL - GENETIC TEST 4000  
143     Clostridium Difficile (Stool) 1400  
144     CLOT RETRACTION TIME 300  
145     CLOTTING TIME 50   3 - 10 Minutes
146     CME CHOLAMINES, PLASMA 8000  
147     CMV VIRAL LOAD BY RT PCR 4000  
148     CMV DNA BY PCR 4000  
149     COBALT 2000   1.8 g/L OR less
150     COCAINE(URINE) 200  
151     COCCYX AP & LAT 500  
152     COCCYX LAT 300  
153     Cockroach ( i6 ) - SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
154     Cocksfoot(Dacctylis glomerata)( g3)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
155     COCONUT (f 36) - SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
156     CODEINE (URINE) 200  
157     COELIAC DISEASE PROFILE 4000   1 ml
158     Cold Agglutinins 4000  
159     COLLAGEN 2000  
160     Colour 0  
161     Common ragweed[Ambrorosia elatior](w1)- SPECI 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
162     COMPLEMENT -TOTAL(CH50) 5000   31 - 60 U/ml

Complement, Total (CH50) - CH50 is a screening test for total complement activity.

Levels of complement may be depressed in genetic deficiency, liver disease, chronic glomerulonephritis, rheumatoid arthritis, hemolytic anemias, graft rejection, systemic lupus erythematosis, acute glomerulonephritis, subacute bacterial endocarditis and cryoglobulinemia.

Elevated complement may be found in acute inflammatory conditions, leukemia, Hodgkin's Disease, sarcoma, and Behcet's Disease.
163     CONE VIEW SELLA 300  
164     CONJUCTIVAL SMEAR FOR GRAM'S STAIN 200  
165     CONSULTATION 250  
166     COOMBS TEST - DIRECT-AUTOMATED 300   1 ML
167     COOMBS TEST - INDIRECT - AUTOMATED 750   1 ml
168     COPPER 500   1 ml MALE : 70 - 140 microgm/dl
FEMALE : 80 - 155 microgm/dl
CHILDREN 6- 12 YRS : 80 - 190 microgm/dl
NEW BORNS : 20 - 70 microgm/dl
PREGNANT WOMEN: 118 - 302 microgm/dl
169     CORTISOL ( AM) 500   1 ml 6 am - 10 am : 6.02 - 18.4 Microgm/dl
4 pm - 8 pm : 2.68 - 10.5 Microgm/dl

Cortisol levels are increased in Cushings Disease and Syndrome and External Steroid treatment.Combining with ACTH measurement will help in differentiating betwwen Primary and Secondary Hypercortisolism.

Lower Levels are seen in Addisons Disease and Sheehans Syndrome.
170     CORTISOL ( PM) 500   1 ml 7 am - 10 am : 6.02 - 18.4 Microgm/dl
4 pm - 8 pm : 2.68 - 10.5 Microgm/dl

Cortisol levels are increased in Cushings Disease and Syndrome and External Steroid treatment.Combining with ACTH measurement will help in differentiating betwwen Primary and Secondary Hypercortisolism.

Lower Levels are seen in Addisons Disease and Sheehans Syndrome.
171     COVID IgG Antibody 750   Less than 0.8 : Negative
>0.80 - <1.0 : Equivoval
More than or Equal to 1.0 : Positive

Interpretive notes :
=====================
This test is for Sero Survelliance only and not for Diagnosis.
A negative Report does not rule out COVID - 19 Infection.
A positive report confirms exposure/Infection with SARS Cov 2 Virus
The presence of Antibody may not protect against reinfection or new infection.
The report must be correlated with Clinical and Imaging Data
172     COVID Total Antibody (ROCHE) 600   Less than 1.0 : Negative
1.0 to 1.2 : Equivocal
More than 1.2 : Positive

Interpretive notes :
=====================
This test is for Sero Survelliance only and not for Diagnosis.
A negative Report does not rule out COVID - 19 Infection.
A positive report confirms exposure/Infection with SARS Cov 2 Virus
The presence of Antibody may not protect against reinfection or new infection.
The report must be correlated with Clinical and Imaging Data
173     COVID 19 by Real Time RT PCR 1200  
174     COVID IgM Ab ( SARS CoV-2 IgM Ab) 900   Interpretation :
Less than 10 AU/ml : Non Reactive
( Less infection Risk of SARS CoV-2)

More than 10 AU/ml : Reactive
( Early infection or High Risk of Infection)

The results must be clinically correlated with other Investigations ,
and Imaging Data.
175     Crab ( f 23)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
176     CRANIUM - USG 900  
177     CREATININE - DIALYSIS FLUID 100  
178     CREATININE - PLEURAL FLUID 150  
179     CREATININE - SERUM 150   0.5 ml Premature Neonates : 0.29 - 1.04 mg/dl
Full Term Neonates : 0.24 - 0.85 mg/dl
2 - 12 Month : 0.17 - 0.42 mg/dl
1 - 3 yrs : 0.24 - 0.41 mg/dl
3 - 5 yrs : 0.31 - 0.47 mg/dl
5 - 7 yrs : 0.32 - 0.59 mg/dl
7 - 9 yrs : 0.40 - 0.60 mg/dl
9 - 11 yrs : 0.39 - 0.73 mg/dl
11 -13 yrs : 0.53 - 0.79 mg/dl
13 -15 yrs : 0.57 - 0.87 mg/dl

Adult :-
Male : 0.7-1.2 mg/dl
Female : 0.5-0.9 mg/dl
180     CREATININE CLEARANCE 400   5 ml urine & 0.5 ml Serum 71 - 151 ml/min
181     CREATININE(ASCITIC FLUID) 150  
182     CRP (CSF) 250  
183     CRYOGLOBULIN - SERUM 200  
184     Cryoglobulins Qualitative 1000  
185     Cryptococcal Antigen Test 1500  
186     CRYPTOCOCCUS ANTIGEN - LATEX TEST 600   0.5 ml
187     CSF ANALYSIS 200  
188     CSF FOR AFB STAIN 200  
189     CSF FOR GRAMS STAIN 200  
190     CT - Abdomen Complete -Plain 3000  
191     CT - Abdomen Complete- Palin and Contrast 4000  
192     CT - Abdomenal Angio 7000  
193     CT - Aortic Angiogram 4000  
194     CT - Both Legs Peripheral Angio 10000  
195     CT - Brain -Plain and Contarst 2200  
196     CT - Brain -Plain Study 2000  
197     CT - Brain and Sinuses 1500  
198     CT - Brain Angio 4000  
199     CT - Carotid Angiogram 4000  
200     CT - Cerebral Angiogram 4000  
201     CT - Cervical Spine 2000  
202     CT - Chest -Plain and Contrast 3000  
203     CT - Chest - HRCT 2000  
204     CT - Chest -Plain Study 2000  
205     CT - Contrast Charges (ABD) 1200  
206     CT - Contrast Charges (M) 1000  
207     CT - Contrast Charges (S) 600  
208     CT - Dorsal Spines 3300  
209     CT - ELBOW 2000  
210     CT - Foot 2500  
211     CT - Inner Ear & Temporal Bones 1800  
212     CT - Knee Joint 2800  
213     CT - KUB 3000  
214     CT - Lower Abdomen Plain & Contrast 3300  
215     CT - Lower Abdomen- Plain 2500  
216     CT - Lower Limb 2000  
217     CT - Lumbar Spines 3300  
218     CT - Neck 2600  
219     CT - Orbits 2000  
220     CT - Paranasal Sinuses 1400  
221     CT - Pelvis 2000  
222     CT - Peripheral Angiogram 4000  
223     CT - Pulmonary Angiogram 4000  
224     CT - Renal Angiogram 4000  
225     CT - SCREENING 1000  
226     CT - Sella 2000  
227     CT - SHOULDER 2000  
228     CT - SI Joints 2800  
229     CT - Thoracic Spine 2500  
230     CT - TM Joints 2800  
231     CT - Upper Abdomen - Palin and Contarst 3300  
232     CT - Upper Abdomen - Plain 2500  
233     CT - WRIST 2000  
234     Cucumber(f244) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
235     Cultivate oat[Avena sativa]( g14)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
236     Cultivate wheat [Tricum aestivum]( g15)- SPECIFIC 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
237     CULTURE & SENSITIVITY 400  
238     CULTURE & SENSITIVITY - VITEK 720  
239     CULTURE & SENSITIVITYY 400  
240     CYCLOSPORINE 2500   2 ml Post Kidney Transplant Trough Level :
Adults:
0-3 Months : 175 - 200 ng/ml
3-6 MOnths : 150 - 200 ng/ml
6-12 Months: 100 - 125 ng/ml
> 12 Months: 75 - 100 ng/ml

Post Liver Transplant Trough Levels :
0-6 Months : 150 -200 ng/ml
> 6 Months : 100 -150 ng/ml

Toxic Level Post Transplant :

1st Month : More than 500 ng/ml
2nd Month : More than 250 ng/ml.
Note : The levels are given as a guidance only. It may vary in a particular patient with Transplant Type, Other Medications ,and protocols.Samples should be drawn immediately prior to the next dose, for trough Level
241     CYFRA 1500  
242     CYSTATIN C 500   20 to 50 years: 0.47 - 1.09 mg/l
243     CYSTICERCOSIS AB IGG 750   1 ml Less than 9.0 : Negative
9.0 - 11.0 : Equivocal
More than 11.0: Positive
244     CYSTICERCOSIS AB IGM 750   1 ml Less than 0.9 : Negative
0.9 - 1.1 : Equivocal
More than 1.1 : Positive
245     CYSTICERCOSIS ANTIBODY IGM (CSF) 400  
246     CYSTICERCOSIS ANTIBODY IGG(CSF) 400  
247     CYTOLOGY 900  
248     CYTOLOGY ( FNAC - 1 SMEAR) 500  
249     CYTOLOGY FOR MALIGNANT CELLS 900  
 
 
 
  © Copyrights 2009 HITECH DIAGNOSTIC CENTRE. All rights reserved   | About Us| Sitemap